from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3729/-

LFCtreatmentdescriptionclass of inhibitor

-0.709

Amikacinug/mL Amikacintranslation

-0.149

Cap5-10ug/mL Capreomycintranslation

-1.531

Rox10-50 ug/mL Roxithromycintranslation

-0.429

SM2-5 ug/mL Streptomycintranslation

-0.336

Tet5-10 ug/mL Tetracyclinetranslation

1.388

Rif0.2-5ug/mL Rifampicintranscription

-0.322

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.708

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.232

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.255

CPZ10-50 ug/mL Chlorpromazinerespiration

0.508

Clofazimine10-13 ug/mL Clofaziminerespiration

0.037

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.481

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.753

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.973

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.120

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.546

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.031

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.938

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.096

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.562

KCN5-20 ug/mL Potassium cyaniderespiration

-0.691

NaN30.2-2 mM Sodium aziderespiration

-0.244

Nigericin50 uM Nigericinrespiration

0.925

TRC10-150 ug/mL Triclosanrespiration

0.392

TRZ10-25 ug/mL Thioridazinerespiration

-0.533

Valinomycin0.5-10 uM Valinomycinrespiration

-0.975

ZnSO42 mM ZnSO4respiration

0.005

menadione6-10 ug/mL Menadionerespiration

0.481

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.007

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.680

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.085

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.588

NRP_1Non-replicating persistence stage 1dosRassociated

-0.098

Amp0.2mg/mL AmpicillincellWall

0.152

Cephalexin20-100 ug/mL CephalexincellWall

-0.271

Cerulenin0.32-5 ug/mL CerulenincellWall

1.175

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.448

EMB10-20 ug/mL EthambutolcellWall

-1.126

Eta12-40 ug/mL EthionamidecellWall

-1.340

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.044

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.077

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.384

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.202

BZA0.12 mg/mL BenzamidearomaticAmides

-0.287

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.997

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.130

H2O24 mM hydrogen peroxideDNAdamaging

-0.538

Levo10 ug/mL LevofloxacinDNAdamaging

-0.165

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.182

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.097

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.213

UVUV-irradiationDNAdamaging

0.736

ARP41-4 ug/mL Antitubercular compound ARP4?

1.057

Antimycin12.5-50 ug/mL Antimycin A?

-0.326

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.679

PA_110-50 ug/mL Antitubercular compound PA-1?

0.382

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.298

PA8240.2-2 ug/mL PA-824?

-0.480

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.076

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.032

Verapamil50 uM Verapamil?

-0.012

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.195

methoxatin10-20 ug/mL Methoxatin?